Intervention Review

You have free access to this content

Vitamin A for non-measles pneumonia in children

  1. Taixiang Wu1,*,
  2. Juan Ni2,
  3. Jiafu Wei2

Editorial Group: Cochrane Acute Respiratory Infections Group

Published Online: 20 JUL 2005

Assessed as up-to-date: 3 AUG 2010

DOI: 10.1002/14651858.CD003700.pub2


How to Cite

Wu T, Ni J, Wei J. Vitamin A for non-measles pneumonia in children. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD003700. DOI: 10.1002/14651858.CD003700.pub2.

Author Information

  1. 1

    West China Hospital, Sichuan University, Chinese Cochrane Centre, Chinese Clinical Trial Registry, Chinese Evidence-Based Medicine Centre, INCLEN Resource and Training Centre, Chengdu, Sichuan, China

  2. 2

    West China Hospital, Sichuan University, Department of Clinical Epidemiology, Chengdu, Sichuan, China

*Taixiang Wu, Chinese Cochrane Centre, Chinese Clinical Trial Registry, Chinese Evidence-Based Medicine Centre, INCLEN Resource and Training Centre, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, Sichuan, 610041, China. txwutx@hotmail.com.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 20 JUL 2005

SEARCH

[Figure 1]
Figure 1. Search strategy in the Chinese databases.
[Figure 2]
Figure 2. Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.
[Figure 3]
Figure 3. Methodological quality summary: review authors' judgements about each methodological quality item for each included study.
[Figure 4]
Figure 4. Forest plot of comparison: 1 Vitamin A versus control, outcome: 1.1 Mortality during hospitalisation.
[Figure 5]
Figure 5. Forest plot of comparison: 1 Vitamin A versus control, outcome: 1.2 Time with signs of pneumonia and treatment issues (continuous).
[Figure 6]
Figure 6. Forest plot of comparison: 1 Vitamin A versus control, outcome: 1.3 Time with signs of pneumonia and treatment issues (dichotomous).
[Figure 7]
Figure 7. Forest plot of comparison: 1 Vitamin A versus control, outcome: 1.5 Time with fever, tachypnoea and hypoxaemia of pneumonia (serum retinol > 200 ug/L).
[Figure 8]
Figure 8. Forest plot of comparison: 1 Vitamin A versus control, outcome: 1.4 Adverse events.
[Figure 9]
Figure 9. Primary outcomes
[Figure 10]
Figure 10. Secondary outcomes
[Figure 11]
Figure 11. Adverse events and secondary outcome
[Analysis 1.1]
Analysis 1.1. Comparison 1 Vitamin A versus control, Outcome 1 Mortality during hospitalisation.
[Analysis 1.2]
Analysis 1.2. Comparison 1 Vitamin A versus control, Outcome 2 Time with signs of pneumonia and treatment issues (continuous).
[Analysis 1.3]
Analysis 1.3. Comparison 1 Vitamin A versus control, Outcome 3 Time with signs of pneumonia and treatment issues (dichotomous).
[Analysis 1.4]
Analysis 1.4. Comparison 1 Vitamin A versus control, Outcome 4 Adverse events.
[Analysis 1.5]
Analysis 1.5. Comparison 1 Vitamin A versus control, Outcome 5 Time with fever, tachypnoea and hypoxaemia of pneumonia (serum retinol > 200 ug/L).